Specific antioxidant selenoproteins are induced in the heart during hypertrophy.

Selenium (Se) is thought to confer cardioprotective effects through the actions of antioxidant selenoprotein enzymes that directly limit levels of ROS such as hydrogen peroxide (H(2)O(2)) or that reverse oxidative damage to lipids and proteins. To determine how the selenoproteome responds to myocardial hypertrophy, two mouse models were employed: triidothyronine (T3)- or isoproterenol (ISO)-treatment. After 7days of T3- and ISO-treatment, cardiac stress was demonstrated by increased H(2)O(2) and caspase-3 activity. Neither treatment produced significant increases in phospholipid peroxidation or TUNEL-positive cells, suggesting that antioxidant systems were protecting the cardiomyocytes from damage. Many selenoprotein mRNAs were induced by T3- and ISO-treatment, with levels of methionine sulfoxide reductase 1 (MsrB1, also called SelR) mRNA showing the largest increases. MsrB enzymatic activity was also elevated in both models of cardiac stress, while glutathione peroxidase (GPx) activity and thioredoxin reductase (Trxrd) activity were moderately and nonsignificantly increased, respectively. Western blot assays revealed a marked increase in MsrB1 and moderate increases in GPx3, GPx4, and Trxrd1, particularly in T3-treated hearts. Thus, the main response of the selenoproteome during hypertrophy does not involve increased GPx1, but increased GPx3 for reducing extracellular H(2)O(2) and increased GPx4, Trxrd1, and MsrB1 for minimizing intracellular oxidative damage.

[1]  H. Hatemi,et al.  OXIDATIVE STRESS IN HEART TISSUE OF HYPERTHYROID AND IRON SUPPLEMENTED RATS , 2001, Journal of toxicology and environmental health. Part A.

[2]  M. Hori,et al.  Oxidative stress and left ventricular remodelling after myocardial infarction. , 2008, Cardiovascular research.

[3]  K. Kugiyama,et al.  Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.

[4]  N. Maulik,et al.  Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase. , 1999 .

[5]  J. Halperin,et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[6]  W. Partata,et al.  Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine , 2007, Molecular and Cellular Biochemistry.

[7]  M. Berry,et al.  Selenoprotein H Is a Redox-sensing High Mobility Group Family DNA-binding Protein That Up-regulates Genes Involved in Glutathione Synthesis and Phase II Detoxification* , 2007, Journal of Biological Chemistry.

[8]  E. Olson,et al.  Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress , 2004, Nature Medicine.

[9]  H. Weissbach,et al.  MsrA protects cardiac myocytes against hypoxia/reoxygenation induced cell death. , 2008, Biochemical and biophysical research communications.

[10]  Frank J Giordano,et al.  Oxygen, oxidative stress, hypoxia, and heart failure. , 2005, The Journal of clinical investigation.

[11]  A. Holmgren,et al.  Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. , 2007, American journal of physiology. Heart and circulatory physiology.

[12]  G. Kryukov,et al.  Selenoprotein H Is a Nucleolar Thioredoxin-like Protein with a Unique Expression Pattern* , 2007, Journal of Biological Chemistry.

[13]  E. Guallar,et al.  Selenium intake and cardiovascular risk: what is new? , 2008, Current opinion in lipidology.

[14]  P. Venditti,et al.  Thyroid hormone-induced oxidative stress , 2006, Cellular and Molecular Life Sciences CMLS.

[15]  M. Berry,et al.  Transcriptional regulation of mammalian selenoprotein expression. , 2009, Biochimica et biophysica acta.

[16]  H. Schunkert,et al.  Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. , 1998, Cardiovascular research.

[17]  V. Gladyshev,et al.  Methionine sulfoxide reduction in mammals: characterization of methionine-R-sulfoxide reductases. , 2003, Molecular biology of the cell.

[18]  W Grossman,et al.  Wall stress and patterns of hypertrophy in the human left ventricle. , 1975, The Journal of clinical investigation.

[19]  R. Guigó,et al.  Characterization of Mammalian Selenoproteomes , 2003, Science.

[20]  N. Plesnila,et al.  Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. , 2008, Cell metabolism.

[21]  Mark E. Anderson,et al.  A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation , 2008, Cell.

[22]  V. Gladyshev,et al.  Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals. , 2007, The Biochemical journal.

[23]  P. Hoffmann,et al.  The human selenoproteome: recent insights into functions and regulation , 2009, Cellular and Molecular Life Sciences.

[24]  D. Kaye,et al.  Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. , 2007, Current medicinal chemistry.

[25]  P. Whanger,et al.  Selenoprotein W accumulates primarily in primate skeletal muscle, heart, brain and tongue , 2004, Molecular and Cellular Biochemistry.

[26]  P. Chatelain,et al.  Prevention by amiodarone of phospholipid depletion in isoproterenol-induced ischemia in rats. , 1987, European journal of pharmacology.

[27]  I. Klein,et al.  Editorial: Thyroid Hormone-Targeting the Heart. , 2001, Endocrinology.

[28]  R. Shohet,et al.  Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  K. Asayama,et al.  Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. , 1987, Endocrinology.

[30]  J. Loscalzo,et al.  Heterozygous Cellular Glutathione Peroxidase Deficiency in the Mouse: Abnormalities in Vascular and Cardiac Function and Structure , 2002, Circulation.

[31]  M. Vobecký,et al.  Selenium protects the immature rat heart against ischemia/reperfusion injury , 2007, Molecular and Cellular Biochemistry.

[32]  Fukun W. Hoffmann,et al.  The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply , 2007, Nucleic acids research.

[33]  R. Woods.  CARDIOPROTECTIVE FUNCTIONS OF ATRIAL NATRIURETIC PEPTIDE AND B‐TYPE NATRIURETIC PEPTIDE: A BRIEF REVIEW , 2004, Clinical and experimental pharmacology & physiology.

[34]  M. Lorgeril,et al.  Selenium and antioxidant defenses as major mediators in the development of chronic heart failure , 2006, Heart Failure Reviews.

[35]  I. Klein,et al.  Thyroid hormone and the cardiovascular system. , 2001, Minerva endocrinologica.

[36]  J. Melendez,et al.  Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. , 2006, Journal of molecular and cellular cardiology.

[37]  Paul R Copeland,et al.  Regulation of gene expression by stop codon recoding: selenocysteine. , 2003, Gene.

[38]  Vadim N. Gladyshev,et al.  Selenoprotein R is a zinc-containing stereo-specific methionine sulfoxide reductase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Pimentel,et al.  Role of reversible, thioredoxin-sensitive oxidative protein modifications in cardiac myocytes. , 2006, Antioxidants & redox signaling.

[40]  L. Schomburg,et al.  Thyroid Hormones Regulate Selenoprotein Expression and Selenium Status in Mice , 2010, PloS one.